Jose Luis Almeda MD
Assistant Professor, Surgery, University of Texas Medical School, San
Join to View Full Profile
1100 E Dove AveSte 201McAllen, TX 78504
Phone+1 956-362-2171
Fax+1 956-362-2214
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jose Almeda, MD is a general surgeon in McAllen, Texas. He is currently licensed to practice medicine in Texas and California. He is an Assistant Professor at University of Texas Medical School.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Surgery, 2002 - 2007- The University of Texas Health Science Center at San AntonioClass of 2002
Certifications & Licensure
CA State Medical License 2007 - Present
TX State Medical License 2009 - 2027
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification P2 Sentinel, Cerner Corporation, 2016-2017
Publications & Presentations
PubMed
- 37 citationsImmune Response in Severe and Non-Severe Coronavirus Disease 2019 (COVID-19) Infection: A Mechanistic Landscape.Kavitha Mukund, Priya Nayak, Chethan Ashokkumar, Sohail Rao, Jose Luis Almeda
Frontiers in Immunology. 2021-10-13 - 8 citationsCirculating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics.Jingjing Jiao, Suet Ying Kwan, Caroline M. Sabotta, Honami Tanaka, Lucas Veillon
Cancer Epidemiology, Biomarkers & Prevention. 2021-06-21 - 6 citationsImpaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipientsChethan Ashokkumar, Vinayak Rohan, Alexander Kroemer, Sohail Rao, George V. Mazariegos
Biorxiv. 2021-05-04
Press Mentions
Studies Underway to Find Out Why RGV Has Highest Rates of Liver DiseaseAugust 7th, 2018
